12:00 AM
 | 
Dec 04, 2000
 |  BC Week In Review  |  Clinical News  |  Clinical Results

INS-1: Phase II

In a preliminary intent-to-treat analysis of INSM's Phase II trial of 246 patients who were not responsive to sulfonylurea therapy, the combination of...

Read the full 92 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >